Cipriani, A., Furukawa, T
approved ADCs with an MMAE payload include brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, disitamab vedotin, tisotumab vedotin, and telisotuzumab vedotin 10,19
The study of about 7,000 children between ages 12 and 18, published this week in the journal JAMA Pediatrics, showed that the medicines were associated with a 33% lower risk over a year
Personalized Nutrition with Genetic Insights Your genetic makeup influences how your gastrointestinal system responds to semaglutide and dietary stressors
Once you get your prescription, get customized treatment delivered quarterly to your door with one of our affordable plans
If you are experiencing persistent fatigue, dizziness, breathlessness or palpitations, do not assume it is simply a normal medication side effect